NCT03885583

Brief Summary

To assess the respiratory and analgesic effects of continuous thoracic paravertebral block versus thoracic epidural in patients undergoing kidney surgery

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 20, 2019

Completed
1 day until next milestone

First Posted

Study publicly available on registry

March 21, 2019

Completed
1 month until next milestone

Study Start

First participant enrolled

May 1, 2019

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 29, 2022

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2022

Completed
Last Updated

December 2, 2022

Status Verified

November 1, 2022

Enrollment Period

3.3 years

First QC Date

March 20, 2019

Last Update Submit

November 30, 2022

Conditions

Keywords

kidney surgerythoracic epidural blockparavertebral block

Outcome Measures

Primary Outcomes (3)

  • vital capacity

    measured by spirometer (Enraf-Nonius, Model SPIRO 601 medical Technologies)

    24 hours after operation

  • forced vital capacity

    measured by spirometer (Enraf-Nonius, Model SPIRO 601 medical Technologies)

    24 hours after operation

  • forced expiratory volume in one second

    measured by spirometer (Enraf-Nonius, Model SPIRO 601 medical Tecnologies)

    24 hours after operation

Secondary Outcomes (2)

  • pain score

    24 hours after operation

  • diaphragmatic excursion

    24 hours after operation

Study Arms (2)

thoracic epidural group

ACTIVE COMPARATOR

patients in this group will receive ultrasound guided thoracic epidural block preoperatively for pain management, continuous infusion of 0.5% bupivacaine through epidural catheter during operation and early post-operative period

Procedure: thoracic epidural block

paravertebral group

ACTIVE COMPARATOR

patients in this group will receive ultrasound guided pararvertebral block preoperatively for pain management, continuous infusion of paravertebral bupivacaine 0.5% through paravetebral catheter during operation and early post-operative period

Procedure: paravertebral block

Interventions

thoracic epidural block with bupivacaine 0.25% will be given in the 8th thoracic space using ultrasound

thoracic epidural group

paravertebral block with 0.25 bupivacaine will be given at the level of the incision using ultrasound

paravertebral group

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • ASA II, III
  • elective kidney surgery

You may not qualify if:

  • patient refusal
  • contraindications to neuraxial blocks
  • pneumonectomy
  • planed postoperative mechanical ventilatoin

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Assiut University Hospital

Asyut, 71516, Egypt

Location

Study Officials

  • Mohammed G Abdelraheem, MD

    Assiut University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant professor

Study Record Dates

First Submitted

March 20, 2019

First Posted

March 21, 2019

Study Start

May 1, 2019

Primary Completion

August 29, 2022

Study Completion

November 30, 2022

Last Updated

December 2, 2022

Record last verified: 2022-11

Locations